COMT and lung carcinoma: In addition, recent studies have shown that tolcapone, a catechol-O-methyltransferase inhibitor used in Parkinson’s disease, decreases cell viability in lung cancer and neuroblastoma cell lines (Forester and Lambert, 2014; Maser et al., 2017).